Eric Olson

Array ( [id] => 5315486 [patent_doc_number] => 20090280084 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-12 [patent_title] => 'NUCLEOSIDE DERIVATIVES FOR TREATMENT OF CALICIVIRIDAE INFECTIONS, INCLUDING NOROVIRUS INFECTIONS' [patent_app_type] => utility [patent_app_number] => 12/421362 [patent_app_country] => US [patent_app_date] => 2009-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20397 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0280/20090280084.pdf [firstpage_image] =>[orig_patent_app_number] => 12421362 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5480676 [patent_doc_number] => 20090203633 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-13 [patent_title] => 'PYRAZOLE DERIVATIVES, MEDICINAL COMPOSITION CONTAINING THE SAME, MEDICINAL USE THEREOF, AND INTERMEDIATE FOR PRODUCTION THEREOF' [patent_app_type] => utility [patent_app_number] => 12/421236 [patent_app_country] => US [patent_app_date] => 2009-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 79838 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20090203633.pdf [firstpage_image] =>[orig_patent_app_number] => 12421236 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5458684 [patent_doc_number] => 20090258836 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-15 [patent_title] => 'EFFECTIVE DELIVERY OF CROSS-SPECIES A3 ADENOSINE-RECEPTOR ANTAGONISTS TO REDUCE INTRAOCULAR PRESSURE' [patent_app_type] => utility [patent_app_number] => 12/419062 [patent_app_country] => US [patent_app_date] => 2009-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 12427 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0258/20090258836.pdf [firstpage_image] =>[orig_patent_app_number] => 12419062 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9749962 [patent_doc_number] => 08841440 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-09-23 [patent_title] => 'Organo-soluble chitosan salts and chitosan-derived biomaterials prepared thereof' [patent_app_type] => utility [patent_app_number] => 12/935660 [patent_app_country] => US [patent_app_date] => 2009-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 11009 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 179 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12935660 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7504078 [patent_doc_number] => 08034923 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2011-10-11 [patent_title] => 'Reagents for reversibly terminating primer extension' [patent_app_type] => utility [patent_app_number] => 12/383776 [patent_app_country] => US [patent_app_date] => 2009-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 11914 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/034/08034923.pdf [firstpage_image] =>[orig_patent_app_number] => 12383776 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6144861 [patent_doc_number] => 20110130440 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-02 [patent_title] => 'NON-NATURAL RIBONUCLEOTIDES, AND METHODS OF USE THEREOF' [patent_app_type] => utility [patent_app_number] => 12/934323 [patent_app_country] => US [patent_app_date] => 2009-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 56528 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20110130440.pdf [firstpage_image] =>[orig_patent_app_number] => 12934323 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8270512 [patent_doc_number] => 08212020 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-07-03 [patent_title] => 'Reagents for reversibly terminating primer extension' [patent_app_type] => utility [patent_app_number] => 12/383306 [patent_app_country] => US [patent_app_date] => 2009-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 22347 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12383306 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5403538 [patent_doc_number] => 20090238852 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-24 [patent_title] => 'METHODS FOR CONTROLLING INTRACELLULAR CALCIUM LEVELS ASSOCIATED WITH AN ISCHEMIC EVENT' [patent_app_type] => utility [patent_app_number] => 12/408377 [patent_app_country] => US [patent_app_date] => 2009-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 29331 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0238/20090238852.pdf [firstpage_image] =>[orig_patent_app_number] => 12408377 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5485980 [patent_doc_number] => 20090275745 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-05 [patent_title] => 'CHITOSAN MANUFACTURING PROCESS' [patent_app_type] => utility [patent_app_number] => 12/406476 [patent_app_country] => US [patent_app_date] => 2009-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 5534 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20090275745.pdf [firstpage_image] =>[orig_patent_app_number] => 12406476 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5303523 [patent_doc_number] => 20090298175 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-03 [patent_title] => 'Steroidal Ligands and Their Use in Gene Switch Modulation' [patent_app_type] => utility [patent_app_number] => 12/404943 [patent_app_country] => US [patent_app_date] => 2009-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 44732 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0298/20090298175.pdf [firstpage_image] =>[orig_patent_app_number] => 12404943 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5993488 [patent_doc_number] => 20110015141 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-20 [patent_title] => 'METHOD FOR TREATING CANCERS HAVING HIGH GLUCOSE REQUIREMENTS EMPLOYING AN SGLT2 INHIBITOR AND COMPOSITIONS THEREOF' [patent_app_type] => utility [patent_app_number] => 12/933013 [patent_app_country] => US [patent_app_date] => 2009-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 9965 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0015/20110015141.pdf [firstpage_image] =>[orig_patent_app_number] => 12933013 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5558771 [patent_doc_number] => 20090270348 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-29 [patent_title] => 'Sulfoalkyl Ether Cyclodextrin Compositions' [patent_app_type] => utility [patent_app_number] => 12/404174 [patent_app_country] => US [patent_app_date] => 2009-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 28813 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0270/20090270348.pdf [firstpage_image] =>[orig_patent_app_number] => 12404174 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5532967 [patent_doc_number] => 20090232755 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-17 [patent_title] => 'COMBINATION THERAPIES FOR TREATING PHOTODAMAGED SKIN' [patent_app_type] => utility [patent_app_number] => 12/403249 [patent_app_country] => US [patent_app_date] => 2009-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4382 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0232/20090232755.pdf [firstpage_image] =>[orig_patent_app_number] => 12403249 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9216483 [patent_doc_number] => 08629283 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-01-14 [patent_title] => 'Compounds that modulate negative-sense, single-stranded RNA virus replication and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/921077 [patent_app_country] => US [patent_app_date] => 2009-03-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 16 [patent_no_of_words] => 59275 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12921077 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10857785 [patent_doc_number] => 08883986 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-11-11 [patent_title] => 'Macrolide polymorphs, compositions comprising such polymorphs, and methods of use and manufacture thereof' [patent_app_type] => utility [patent_app_number] => 12/397686 [patent_app_country] => US [patent_app_date] => 2009-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 12936 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12397686 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8410324 [patent_doc_number] => 08273721 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-09-25 [patent_title] => 'Combination treatment for bladder cancer' [patent_app_type] => utility [patent_app_number] => 12/397831 [patent_app_country] => US [patent_app_date] => 2009-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3152 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12397831 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8560206 [patent_doc_number] => 08334269 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-12-18 [patent_title] => 'Composition comprising Xanthoceras sorbifolia extracts, compounds isolated from same, methods for preparing same and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/392795 [patent_app_country] => US [patent_app_date] => 2009-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 51 [patent_figures_cnt] => 79 [patent_no_of_words] => 59384 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12392795 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6136287 [patent_doc_number] => 20110009348 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-13 [patent_title] => 'CARBOHYDRATE GEL' [patent_app_type] => utility [patent_app_number] => 12/920177 [patent_app_country] => US [patent_app_date] => 2009-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5765 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20110009348.pdf [firstpage_image] =>[orig_patent_app_number] => 12920177 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9412984 [patent_doc_number] => 08697020 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-04-15 [patent_title] => 'Silica magnetic particles having a spherical form and a process for preparing the same' [patent_app_type] => utility [patent_app_number] => 12/867413 [patent_app_country] => US [patent_app_date] => 2009-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 8476 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12867413 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9286424 [patent_doc_number] => 08642754 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-02-04 [patent_title] => 'Photoresponsive nucleic acid manufacturing method' [patent_app_type] => utility [patent_app_number] => 12/867694 [patent_app_country] => US [patent_app_date] => 2009-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 8 [patent_no_of_words] => 9375 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12867694 [rel_patent_id] =>[rel_patent_doc_number] =>)